Company
ASLAN Pharmaceuticals Ltd (0001722926)
Standardized SEC financial data for ASLAN Pharmaceuticals Ltd — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001722926 · Pharmaceutical Preparations.
Return on equity
332.8%
Income statement
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Cost of revenue | — | $407K | — | — | — | — |
| Gross profit | — | $2.6M | — | — | — | $12.0M |
| R&D expense | $31.8M | $16.6M |
Standardized from ASLAN Pharmaceuticals Ltd's SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Total assets | $52.9M | $23.3M | $16.1M | $94.5M | $61.2M | $24.6M |
| Total liabilities |
Get 0001722926 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001722926/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001722926/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"